Actively Recruiting

All Genders
ID03992625

Clinical Outcomes for Deep Brain Stimulation for Parkinson Disease, Tremor, and Dystonia

Led by Washington University School of Medicine · Updated on 2019-06-20

1000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

W

Washington University School of Medicine

Lead Sponsor

N

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are collecting long-term clinical outcomes of patients who receive deep brain stimulation (DBS) to treat movement disorders such as Parkinson disease, essential tremor, and dystonia. The study is observational and aims to retrospectively compare and track the risks, benefits, and complications associated with this therapy over time. This research is led by Washington University School of Medicine. Participants undergo deep brain stimulation, which involves high-frequency electrical stimulation of deep brain nuclei to manage movement disorders. There are no experimental drug treatments involved, and the study follows patients who have already received DBS to observe their progress and clinical outcomes. During the study, researchers monitor changes in patient movement and function using tools like the Unified Parkinson's Disease Rating Scale (UPDRS), measuring changes at one year after DBS compared to before surgery. The study tracks these outcomes over time to better understand the effects and safety of DBS in this patient population. Participation involves clinical assessments and follow-up evaluations.

CONDITIONS

Brief Title

Clinical Outcomes for Deep Brain Stimulation

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of levodopa-responsive Parkinson disease OR
  • Diagnosis of medically refractory essential tremor OR
  • Diagnosis of medically refractory dystonia
Not Eligible

You will not qualify if you...

  • Dementia with Mattis Dementia Rating Scale score less than 130
  • Structural brain abnormalities that prevent intracranial surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Implementation

Duration - Varies based on individual treatment plans

Participants undergo deep brain stimulation, a device-based procedure for treating movement disorders.

Long-term Monitoring

Duration - Up to 1 year after device implementation

Participants are monitored to assess outcomes and changes following deep brain stimulation.

Periodic visits during the year after treatment

Trial Site Locations

Total: 1 location

1

Washington University in St Louis

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

M

Mwiza Ushe, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

10,000 STEP CLUB: Community Walking Program to Decrease Sede...

Parkinson Disease

Actively Recruiting

1 location

18F-DOPA II - PET Imaging Optimization

Congenital Hyperinsulinism

Actively Recruiting

1 location

24-month Open-label Study to Evaluate Safety, Tolerability, ...

Parkinson Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here